US Stock MarketDetailed Quotes

MDCX Medicus Pharma

Watchlist

2.650
0.0000.00%

Close Nov 14 16:00 ET

2.370
-0.280-10.57%

Pre 09:19 ET

28.74MMarket Cap0.00P/E (TTM)

Medicus Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

1,480.74%4.04M

342.82%1.78M

207.85%3.01M

1,079.95%2.13M

-16.42%226.81K

-1.27%255.69K

50.30%402.53K

-32.12%978.42K

180.27K

271.36K

Selling and administrative expenses

1,329.78%2.95M

331.91%1.44M

748.87%2.82M

2,208.60%2.09M

126.77%186.42K

182.34%206.12K

286.90%333.42K

28.69%332.03K

--90.64K

--82.21K

-General and administrative expense

1,329.78%2.95M

331.91%1.44M

748.87%2.82M

2,208.60%2.09M

126.77%186.42K

182.34%206.12K

286.90%333.42K

28.69%332.03K

--90.64K

--82.21K

Research and development costs

2,055.88%1.07M

357.78%316.39K

-70.05%193.58K

-61.51%34.5K

-78.64%40.4K

-73.34%49.58K

-61.95%69.11K

-45.38%646.38K

--89.63K

--189.15K

Depreciation amortization depletion

--26.04K

----

--0

----

-Depreciation and amortization

--26.04K

----

--0

----

Operating profit

-1,480.74%-4.04M

-342.82%-1.78M

-207.85%-3.01M

-1,079.95%-2.13M

16.42%-226.81K

1.27%-255.69K

-50.30%-402.53K

32.12%-978.42K

-180.27K

-271.36K

Net non-operating interest income expense

77.12%-88.26K

97.31%-9.01K

-6.21%-1.17M

-60.60%-450.34K

-41.64%-385.79K

-46.63%-334.56K

-59.55%-1.1M

-321.33K

-280.41K

Non-operating interest expense

-63.52%88.26K

-95.28%9.01K

40.29%739.1K

--0

124.45%306.48K

88.26%241.92K

126.20%190.7K

356.50%526.83K

--177.47K

--136.55K

Total other finance cost

----

-25.00%431.59K

--0

0.00%143.86K

-0.00%143.86K

0.00%143.86K

0.00%575.45K

--143.86K

Other net income (expense)

-769.93%-2.6M

-501.81%-720.8K

-1,494.44%-2.29M

1,301.82%152.81K

339.09%253.17K

404.44%388.31K

179.39K

163.98K

Gain on sale of security

----

427.53%670.1K

--0

61.08%264.12K

1,301.82%152.81K

339.09%253.17K

-365.78%-204.6K

---413.51K

--163.98K

Special income (charges)

----

--0

----

--592.9K

----

-Less:Other special charges

----

---592.9K

----

Other non- operating income (expenses)

----

---3.27M

---720.8K

---2.55M

----

Income before tax

-745.18%-4.13M

-270.21%-1.79M

-300.86%-6.78M

-783.84%-2.85M

-664.25%-2.96M

10.18%-488.67K

-10.40%-483.92K

17.66%-1.69M

-322.21K

-387.79K

Income tax

Net income

-745.18%-4.13M

-270.21%-1.79M

-300.86%-6.78M

-783.84%-2.85M

-664.25%-2.96M

10.18%-488.67K

-10.40%-483.92K

17.66%-1.69M

-322.21K

-387.79K

Net income continuous Operations

-745.18%-4.13M

-270.21%-1.79M

-300.86%-6.78M

-783.84%-2.85M

-664.25%-2.96M

10.18%-488.67K

-10.40%-483.92K

17.66%-1.69M

---322.21K

---387.79K

Minority interest income

Net income attributable to the parent company

-745.19%-4.13M

-270.21%-1.79M

-300.86%-6.78M

-783.84%-2.85M

-664.25%-2.96M

10.18%-488.67K

-10.40%-483.92K

17.66%-1.69M

-322.21K

-387.79K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-745.19%-4.13M

-270.21%-1.79M

-300.86%-6.78M

-783.84%-2.85M

-664.25%-2.96M

10.18%-488.67K

-10.40%-483.92K

17.66%-1.69M

-322.21K

-387.79K

Basic earnings per share

-723.55%-0.5

-265.92%-0.22

-822.65%-1.94

-780.80%-0.3526

-664.26%-0.3682

10.18%-0.0607

-10.40%-0.0601

17.66%-0.2103

-0.04

-0.0482

Diluted earnings per share

-723.55%-0.5

-265.92%-0.22

-822.65%-1.94

-780.80%-0.3526

-664.26%-0.3682

10.18%-0.0607

-10.40%-0.0601

17.66%-0.2103

-0.04

-0.0482

Dividend per share

Currency Unit

USD

Audit Opinions

Unaudited

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	1,480.74%4.04M	342.82%1.78M	207.85%3.01M	1,079.95%2.13M	-16.42%226.81K	-1.27%255.69K	50.30%402.53K	-32.12%978.42K	180.27K	271.36K
Selling and administrative expenses	1,329.78%2.95M	331.91%1.44M	748.87%2.82M	2,208.60%2.09M	126.77%186.42K	182.34%206.12K	286.90%333.42K	28.69%332.03K	--90.64K	--82.21K
-General and administrative expense	1,329.78%2.95M	331.91%1.44M	748.87%2.82M	2,208.60%2.09M	126.77%186.42K	182.34%206.12K	286.90%333.42K	28.69%332.03K	--90.64K	--82.21K
Research and development costs	2,055.88%1.07M	357.78%316.39K	-70.05%193.58K	-61.51%34.5K	-78.64%40.4K	-73.34%49.58K	-61.95%69.11K	-45.38%646.38K	--89.63K	--189.15K
Depreciation amortization depletion	--26.04K	--26.04K	----	----	----	--0	--0	----	----	----
-Depreciation and amortization	--26.04K	--26.04K	----	----	----	--0	--0	----	----	----
Operating profit	-1,480.74%-4.04M	-342.82%-1.78M	-207.85%-3.01M	-1,079.95%-2.13M	16.42%-226.81K	1.27%-255.69K	-50.30%-402.53K	32.12%-978.42K	-180.27K	-271.36K
Net non-operating interest income expense	77.12%-88.26K	97.31%-9.01K	-6.21%-1.17M	0	-60.60%-450.34K	-41.64%-385.79K	-46.63%-334.56K	-59.55%-1.1M	-321.33K	-280.41K
Non-operating interest expense	-63.52%88.26K	-95.28%9.01K	40.29%739.1K	--0	124.45%306.48K	88.26%241.92K	126.20%190.7K	356.50%526.83K	--177.47K	--136.55K
Total other finance cost	----	----	-25.00%431.59K	--0	0.00%143.86K	-0.00%143.86K	0.00%143.86K	0.00%575.45K	--143.86K	--143.86K
Other net income (expense)			-769.93%-2.6M	-501.81%-720.8K	-1,494.44%-2.29M	1,301.82%152.81K	339.09%253.17K	404.44%388.31K	179.39K	163.98K
Gain on sale of security	----	----	427.53%670.1K	--0	61.08%264.12K	1,301.82%152.81K	339.09%253.17K	-365.78%-204.6K	---413.51K	--163.98K
Special income (charges)	----	----	--0	----	----	----	----	--592.9K	----	----
-Less:Other special charges	----	----	----	----	----	----	----	---592.9K	----	----
Other non- operating income (expenses)	----	----	---3.27M	---720.8K	---2.55M	----	----	----	----	----
Income before tax	-745.18%-4.13M	-270.21%-1.79M	-300.86%-6.78M	-783.84%-2.85M	-664.25%-2.96M	10.18%-488.67K	-10.40%-483.92K	17.66%-1.69M	-322.21K	-387.79K
Income tax
Net income	-745.18%-4.13M	-270.21%-1.79M	-300.86%-6.78M	-783.84%-2.85M	-664.25%-2.96M	10.18%-488.67K	-10.40%-483.92K	17.66%-1.69M	-322.21K	-387.79K
Net income continuous Operations	-745.18%-4.13M	-270.21%-1.79M	-300.86%-6.78M	-783.84%-2.85M	-664.25%-2.96M	10.18%-488.67K	-10.40%-483.92K	17.66%-1.69M	---322.21K	---387.79K
Minority interest income
Net income attributable to the parent company	-745.19%-4.13M	-270.21%-1.79M	-300.86%-6.78M	-783.84%-2.85M	-664.25%-2.96M	10.18%-488.67K	-10.40%-483.92K	17.66%-1.69M	-322.21K	-387.79K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-745.19%-4.13M	-270.21%-1.79M	-300.86%-6.78M	-783.84%-2.85M	-664.25%-2.96M	10.18%-488.67K	-10.40%-483.92K	17.66%-1.69M	-322.21K	-387.79K
Basic earnings per share	-723.55%-0.5	-265.92%-0.22	-822.65%-1.94	-780.80%-0.3526	-664.26%-0.3682	10.18%-0.0607	-10.40%-0.0601	17.66%-0.2103	-0.04	-0.0482
Diluted earnings per share	-723.55%-0.5	-265.92%-0.22	-822.65%-1.94	-780.80%-0.3526	-664.26%-0.3682	10.18%-0.0607	-10.40%-0.0601	17.66%-0.2103	-0.04	-0.0482
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unaudited	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data